Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M, Baschat A A, Hansmann M, Gembruch U
Department of Obstetrics and Prenatal Medicine, University of Bonn, Bonn, Germany.
Ultrasound Obstet Gynecol. 2005 Jul;26(1):4-15. doi: 10.1002/uog.1918.
To assess the spectrum of anomalies associated with fetal heart block and to identify possible prognostic markers.
Retrospective review of all cases of second- or third-degree heart block identified in two tertiary referral centers in Germany (Bonn and Lübeck) and one in the USA (Baltimore).
Sixty fetuses with heart block were identified in the study period. Thirty-two had complex cardiac malformations, 31 of them associated with left isomerism. The outcomes of these fetuses were 22 terminations of pregnancy (TOP), three intrauterine fetal deaths (IUFD), three neonatal deaths (NND), two childhood deaths (CD) and there were two survivors. In 20 cases without complex cardiac malformations maternal antinuclear-antibodies were detected. Their outcomes were 2 TOP, 1 IUFD, 1 NND and 16 survived. The remaining eight cases had neither complex cardiac malformations nor associated maternal antibodies. Their outcomes were 1 TOP, 2 IUFD, 2 NND and 3 survived. After exclusion of terminated cases, hydrops as well as the presence of cardiac defects was significantly associated with non-survival (P < 0.01). The cardiothoracic circumference ratio was significantly higher in hydropic fetuses and significantly negatively correlated with survival in immune-mediated cases (P < 0.01). Atrial and ventricular frequencies and their evolution did not accurately predict fetal or neonatal outcome. Sympathomimetic treatment in seven cases was not associated with favorable fetal outcome in cases of hydrops or cardiac malformations.
The most important marker predicting adverse outcome in cases of heart block is fetal hydrops, followed by the association with complex cardiac malformations. Cases without cardiac malformations have a significantly better prognosis, especially in the absence of severe cardiomegaly.
评估与胎儿心脏传导阻滞相关的异常谱,并确定可能的预后标志物。
回顾性分析德国两个三级转诊中心(波恩和吕贝克)以及美国一个中心(巴尔的摩)确诊的所有二度或三度心脏传导阻滞病例。
在研究期间共识别出60例心脏传导阻滞胎儿。32例有复杂心脏畸形,其中31例与左心异构有关。这些胎儿的结局为22例妊娠终止(TOP)、3例宫内胎儿死亡(IUFD)、3例新生儿死亡(NND)、2例儿童期死亡(CD),2例存活。20例无复杂心脏畸形的病例检测到母体抗核抗体。其结局为2例TOP、1例IUFD、1例NND,16例存活。其余8例既无复杂心脏畸形也无相关母体抗体。其结局为1例TOP、2例IUFD、2例NND,3例存活。排除终止妊娠的病例后,水肿以及心脏缺陷的存在与非存活显著相关(P<0.01)。水肿胎儿的心胸周长比显著更高,且在免疫介导的病例中与存活显著负相关(P<0.01)。心房和心室频率及其变化不能准确预测胎儿或新生儿结局。7例使用拟交感神经药物治疗的水肿或心脏畸形病例,胎儿结局均不佳。
预测心脏传导阻滞病例不良结局的最重要标志物是胎儿水肿,其次是与复杂心脏畸形相关。无心脏畸形的病例预后明显更好,尤其是在无严重心脏扩大的情况下。